late-stage trial all news related to

Moderna funding nears $1 billion as vaccine study starts

July 27, 2020

Moderna Inc. climbed as much as 11% Monday after getting a second round of U.S. funding for an experimental vaccine for covid-19 and kicking off its late-stage trial.

All News late-stage trial In Focus late-stage trial BreakingNews of late-stage trial Your Interested Follow Story late-stage trial

Moderna funding nears $1 billion as vaccine study starts